Page 2 - Best Lung cancer stage 4 doctors in Turkey: TOP 32 doctors

Associate Professor Emrah Eraslan specializes in lung cancer treatment at Private Koru Ankara Hospital, bringing extensive experience in oncology.

• Board-certified in medical oncology with over 12 years of experience
• Completed specialized training at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital
• Published multiple research papers contributing to cancer treatment advancements
• Offers comprehensive care for various cancer types

Prof. Sezer Saglam specializes in medical oncology with a focus on gastrointestinal cancers at Gayrettepe Florence Nightingale Hospital.

• Professor of Medical Oncology since 2016
• Completed Medical Oncology Fellowship at Istanbul University
• Member of ESMO, ASCO, and Turkish Medical Oncology Association
• Specializes in gastrointestinal oncology since 2005

Dr. Ece trained at MD Anderson Cancer Center – one of the world's top cancer hospitals – specializing in lung cancer. She brings this expertise to Liv Hospital Ulus.

• Postdoctoral fellowship in lung cancer at MD Anderson
• Trained in interventional bronchoscopy at Johns Hopkins
• Executive Board Member of Turkish Lung Cancer Society
• Published 48 international research papers
• Fellow of American College of Chest Physicians

Professor Bilir specializes in lung cancer treatment, combining clinical expertise with academic research at Sakarya University.

• Board-certified in medical oncology with over 15 years of experience
• Member of ASCO and ESMO – stays updated with global oncology standards
• Completed research fellowship at Northeastern University in Boston
• Currently pursuing Ph.D. in inorganic chemistry to enhance cancer treatment approaches

Specializes in minimally invasive thoracic surgery for lung cancer – Dr. Adnansayar performs thoracoscopic and robotic procedures at Liv Hospital Ulus.

• Focused on lung cancers and trachea surgery
• Skilled in lung transplantation and pleural disease surgery
• Also experienced in pediatric thoracic surgeries
• Graduated from Istanbul University Faculty of Medicine

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.